Axsome Therapeutics, Inc. Quarterly Current Ratio in % from Q3 2016 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Axsome Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q3 2016 to Q3 2024.
  • Axsome Therapeutics, Inc. Current Ratio for the quarter ending September 30, 2024 was 286 %, a 22.7% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 286 -84.1 -22.7% Sep 30, 2024
Q2 2024 332 -22.9 -6.46% Jun 30, 2024
Q1 2024 389 +87.4 +28.9% Mar 31, 2024
Q4 2023 392 +84.7 +27.5% Dec 31, 2023
Q3 2023 371 +18.5 +5.25% Sep 30, 2023
Q2 2023 355 +13.5 +3.95% Jun 30, 2023
Q1 2023 302 -150 -33.1% Mar 31, 2023
Q4 2022 308 -243 -44.1% Dec 31, 2022
Q3 2022 352 -301 -46.1% Sep 30, 2022
Q2 2022 341 -444 -56.5% Jun 30, 2022
Q1 2022 452 -388 -46.2% Mar 31, 2022
Q4 2021 551 -285 -34.1% Dec 31, 2021
Q3 2021 654 -211 -24.4% Sep 30, 2021
Q2 2021 786 +76.7 +10.8% Jun 30, 2021
Q1 2021 840 +211 +33.6% Mar 31, 2021
Q4 2020 835 +266 +46.8% Dec 31, 2020
Q3 2020 865 +550 +175% Sep 30, 2020
Q2 2020 709 +405 +133% Jun 30, 2020
Q1 2020 629 +382 +154% Mar 31, 2020
Q4 2019 569 +371 +188% Dec 31, 2019
Q3 2019 315 +75.9 +31.7% Sep 30, 2019
Q2 2019 304 +8.32 +2.81% Jun 30, 2019
Q1 2019 247 -104 -29.6% Mar 31, 2019
Q4 2018 198 -214 -51.9% Dec 31, 2018
Q3 2018 239 -245 -50.6% Sep 30, 2018
Q2 2018 296 -222 -42.8% Jun 30, 2018
Q1 2018 351 -229 -39.5% Mar 31, 2018
Q4 2017 411 -277 -40.2% Dec 31, 2017
Q3 2017 484 -434 -47.3% Sep 30, 2017
Q2 2017 518 Jun 30, 2017
Q1 2017 581 Mar 31, 2017
Q4 2016 688 Dec 31, 2016
Q3 2016 918 Sep 30, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.